These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26466806)

  • 21. Analysis of pharmaceuticals in fish using liquid chromatography-tandem mass spectrometry.
    Ramirez AJ; Mottaleb MA; Brooks BW; Chambliss CK
    Anal Chem; 2007 Apr; 79(8):3155-63. PubMed ID: 17348635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein quantification by LC-MS: a decade of progress through the pages of
    van de Merbel NC
    Bioanalysis; 2019 Apr; 11(7):629-644. PubMed ID: 30983409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case studies: the impact of nonanalyte components on LC-MS/MS-based bioanalysis: strategies for identifying and overcoming matrix effects.
    Li F; Ewles M; Pelzer M; Brus T; Ledvina A; Gray N; Koupaei-Abyazani M; Blackburn M
    Bioanalysis; 2013 Oct; 5(19):2409-41. PubMed ID: 24066625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic investigation of ion suppression and enhancement effects of fourteen stable-isotope-labeled internal standards by their native analogues using atmospheric-pressure chemical ionization and electrospray ionization and the relevance for multi-analyte liquid chromatographic/mass spectrometric procedures.
    Remane D; Wissenbach DK; Meyer MR; Maurer HH
    Rapid Commun Mass Spectrom; 2010 Apr; 24(7):859-67. PubMed ID: 20196193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hazards in chromatographic bioanalysis method development and applications.
    Hooshfar S; Bartlett MG
    Biomed Chromatogr; 2017 Jan; 31(1):. PubMed ID: 27696464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential bias and mitigations when using stable isotope labeled parent drug as internal standard for LC-MS/MS quantitation of metabolites.
    Jian W; Edom RW; Xu Y; Gallagher J; Weng N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3267-76. PubMed ID: 21056016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultraviolet derivatization of low-molecular-mass thiols for high performance liquid chromatography and capillary electrophoresis analysis.
    Kuśmierek K; Chwatko G; Głowacki R; Kubalczyk P; Bald E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(17-18):1290-307. PubMed ID: 21112259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Data-driven approach for cross-species comparative metabolite exposure assessment: how to establish fundamental bioanalytical parameters for the peak area ratio method.
    Gao H; Obach RS
    Bioanalysis; 2014 Mar; 6(5):641-50. PubMed ID: 24620806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LC-MS systems for quantitative bioanalysis.
    van Dongen WD; Niessen WM
    Bioanalysis; 2012 Oct; 4(19):2391-9. PubMed ID: 23088465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Derivatization methods for LC-MS analysis of endogenous compounds.
    Zhu Y; Deng P; Zhong D
    Bioanalysis; 2015 Oct; 7(19):2557-81. PubMed ID: 26477276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of polar drugs in human plasma with liquid chromatography-tandem mass spectrometry.
    Deng P; Chen X; Zhong D
    Bioanalysis; 2009 Apr; 1(1):187-203. PubMed ID: 21083196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput quantitative bioanalysis by LC/MS/MS.
    Jemal M
    Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
    Mück W
    Pharmazie; 1999 Sep; 54(9):639-44. PubMed ID: 10522267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conference report: the 3rd Global CRO Council for Bioanalysis at the International Reid Bioanalytical Forum.
    Breda M; Garofolo F; Caturla MC; Couerbe P; Maltas J; White P; Struwe P; Sangster T; Riches S; Hillier J; Garofolo W; Zimmerman T; Pawula M; Collins E; Schoutsen D; Wieling J; Green R; Houghton R; Jeanbaptiste B; Claassen Q; Harter T; Seymour M
    Bioanalysis; 2011 Dec; 3(24):2721-7. PubMed ID: 22185271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 16th Annual Land O'Lakes Bioanalytical Conference.
    Burns EC; Guthrie RH; Fluhler EN; Stubbs RJ; Bateman K; King L; Moran J
    Bioanalysis; 2015 Nov; 7(21):2731-4. PubMed ID: 26563751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted analysis of multiple pharmaceuticals, plant toxins and other secondary metabolites in herbal dietary supplements by ultra-high performance liquid chromatography-quadrupole-orbital ion trap mass spectrometry.
    Vaclavik L; Krynitsky AJ; Rader JI
    Anal Chim Acta; 2014 Jan; 810():45-60. PubMed ID: 24439505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic evaluation of the root cause of non-linearity in liquid chromatography/tandem mass spectrometry bioanalytical assays and strategy to predict and extend the linear standard curve range.
    Yuan L; Zhang D; Jemal M; Aubry AF
    Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1465-74. PubMed ID: 22592990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarker measurements: how far have we come and where are we heading?
    Amaravadi L
    Bioanalysis; 2016 Dec; 8(23):2383-2386. PubMed ID: 27855506
    [No Abstract]   [Full Text] [Related]  

  • 40. Inductively coupled plasma-MS in drug development: bioanalytical aspects and applications.
    van Heuveln F; Meijering H; Wieling J
    Bioanalysis; 2012 Aug; 4(15):1933-65. PubMed ID: 22943623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.